Department of Anatomy, Histology and Embryology, Science Research Center, Institute of Neuroscience (M.-H.B., G.-Y.L., L.T., L.-P.D., J.-M.L.), and Department of Pharmacology (X.-S.H.), Changsha Medical University, Changsha, China
Department of Anatomy, Histology and Embryology, Science Research Center, Institute of Neuroscience (M.-H.B., G.-Y.L., L.T., L.-P.D., J.-M.L.), and Department of Pharmacology (X.-S.H.), Changsha Medical University, Changsha, China.
Mol Pharmacol. 2018 Apr;93(4):368-375. doi: 10.1124/mol.117.110650. Epub 2018 Feb 7.
Angiogenesis in atherosclerotic plaque promotes plaque growth, causes plaque hemorrhage, and violates plaque stability. LINC00657 is a long noncoding RNA highly conserved and abundantly expressed in vascular endothelial cells. The present study was designed to investigate the effects and mechanisms of LINC00675 on low concentrations of oxidized low-density lipoprotein (oxLDL)-induced angiogenesis. Cell proliferation, transwell, wound healing, and tube formation assays were conducted to detect the effects of low concentrations of oxLDL on angiogenesis; the results discovered that oxLDL promoted cell proliferation, migration, and tube formation. oxLDL also upregulated LINC00657 expression. Inhibition of LINC00657 by siRNA significantly suppressed oxLDL-induced endothelial cell proliferation, migration, and tube formation. Bioinformatic assay indicated six binding sites in the LINC00657 sequence to miR-590-3p. The upregulation of LINC00657 was related to the downregulation of miR-590-3p in oxLDL-treated endothelial cells; while downregulation of LINC00657 resulted in upregulation of miR-590-3p. The antiangiogenesis effects of si-LINC00657 were partly abrogated by miR-590-3p inhibitor. Further dual-luciferase assay found miR-590-3p inhibited the expression of hypoxia-inducible factor 1 (HIF-1) by binding to the position of 689-696 in HIF-1 3'-untranslated region directly. MiR-590-3p also inhibited the oxLDL-induced upregulation of HIF-1, vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9). These results suggested that in oxLDL-treated endothelial cells, LINC00657 acted as a miR-590-3p sponge to attenuate the suppression of miR-590-3p on HIF-1, and to promote angiogenesis through VEGF, MMP-2, and MMP-9. The present study provided new insight into the roles of LINC00657 and miR-590-3p in preventing oxLDL-induced angiogenesis and may provide a novel strategy for atherosclerosis treatment.
动脉粥样硬化斑块中的血管生成促进斑块生长、导致斑块出血,并破坏斑块稳定性。LINC00657 是一种长链非编码 RNA,在血管内皮细胞中高度保守且大量表达。本研究旨在探讨 LINC00657 对低浓度氧化型低密度脂蛋白(oxLDL)诱导的血管生成的作用及其机制。通过细胞增殖、Transwell、划痕愈合和管形成实验检测低浓度 oxLDL 对血管生成的影响;结果发现 oxLDL 促进了细胞增殖、迁移和管形成。oxLDL 还上调了 LINC00657 的表达。siRNA 抑制 LINC00657 显著抑制 oxLDL 诱导的内皮细胞增殖、迁移和管形成。生物信息学分析表明,LINC00657 序列中有六个与 miR-590-3p 结合的位点。oxLDL 处理的内皮细胞中 LINC00657 的上调与 miR-590-3p 的下调有关;而 LINC00657 的下调导致 miR-590-3p 的上调。si-LINC00657 的抗血管生成作用部分被 miR-590-3p 抑制剂所消除。进一步的双荧光素酶报告基因实验发现,miR-590-3p 通过直接结合 HIF-1 3'UTR 的 689-696 位抑制 HIF-1 的表达。miR-590-3p 还抑制了 oxLDL 诱导的 HIF-1、血管内皮生长因子(VEGF)、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的上调。这些结果表明,在 oxLDL 处理的内皮细胞中,LINC00657 作为 miR-590-3p 的海绵,减弱了 miR-590-3p 对 HIF-1 的抑制作用,并通过 VEGF、MMP-2 和 MMP-9 促进血管生成。本研究为 LINC00657 和 miR-590-3p 在预防 oxLDL 诱导的血管生成中的作用提供了新的见解,并可能为动脉粥样硬化的治疗提供新的策略。